| Listing of Equity Shares of Global Health Limited |
Trading Members of the Exchange are hereby informed that effective from Wednesday, November 16, 2022, the equity shares of Global Health Limited shall be listed and admitted to dealings on the Exchange in the list of 'B ' Group of Securities.
|
Name of the company
|
Global Health Limited
|
|
Registered Office:
|
Medanta – Mediclinic, E-18,
Defence Colony, New Delhi,
Delhi 110 024, India
Tel :+91 124 483 4060
Email : compliance@medanta.org
Website : https://www.medanta.org
|
|
No. of Securities
|
26,81,84,882 Equity Shares Of Rs.2/- each fully paid up
|
|
Distinctive Number range
|
1 To 268184882
|
|
Scrip ID on BOLT System
|
MEDANTA
|
|
Abbreviated Name on BOLT System
|
MEDANTA
|
|
Scrip Code
|
543654
|
|
ISIN No.
|
INE474Q01031
|
|
Market Lot
|
1
|
|
Issue Price for the current Public issue
|
Rs. 336/- per share (Face Value of Rs. 2/- and premium of Rs. 334/-)
|
|
Date of Allotment in the public issue:
|
November 11, 2022
|
|
Pari Pasu
|
Yes
|
|
Financial Year
|
Mar-31
|
|
Lock in detail
|
As per Annexure I
|
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form.
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, November 16, 2022. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c)The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records
d) The Registrar to the issue as mentioned in the prospectus is given below
|
KFin Technologies Limited
(formerly known as KFin Technologies Private Limited)
Address: Selenium, Tower-B Plot 31 and 32, Financial District Nanakramguda, Serilingampally Hyderabad, Rangareddi 500 032 Telangana, India
Tel: +91 40 6716 2222
E-mail: globalhealth.ipo@kfintech.com
Website: www.kfintech.com
Investor Grievance E-mail: einward.ris@kfintech.com
Contact person: M Murali Krishna
SEBI Registration No.: INR000000221
|
e) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
|
a) At the company:
Rahul Ranjan
Company Secretary and Compliance Officer
|
Address:
Medanta – Mediclinic, E-18,
Defence Colony, New Delhi,
Delhi 110 024, India
Tel :+91 124 483 4060
Email : compliance@medanta.org
Website : https://www.medanta.org
|
|
b) At the Exchange:
Mr. Raghavendra Bhat
Associate Manager
|
Tel.: (91) 022 2272 8915
|
Rupal Khandelwal
Assistant General Manager
Tuesday, November 14,2022 |